Engineering an Evolution in Cell Therapy
Century Therapeutics is an innovative biotechnology company building an allogeneic iPSC-derived cell therapy platform for autoimmune diseases and cancer. The company integrates gene editing, protein engineering, and advanced manufacturing to develop off-the-shelf NK and T cell therapies. Century is led by industry veterans with decades of R&D and commercialization experience in cell therapy.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2026
Apr 2024
Jun 2021
Mar 2021
Jul 2019
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
